Solid Biosciences (SLDB) Net Cash Flow (QoQ) (2017 - 2026)
Solid Biosciences (SLDB) Net Cash Flow (QoQ) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Solid Biosciences |
789.54 Mn |
408.86 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
17,020.96% |
| Dec 31, 2025 |
98.20% |
| Sep 30, 2025 |
-8.12% |
| Jun 30, 2025 |
-155.01% |
| Mar 31, 2025 |
722.19% |
| Dec 31, 2024 |
150.45% |
| Sep 30, 2024 |
-45.26% |
| Jun 30, 2024 |
-149.69% |
| Mar 31, 2024 |
74.39% |
| Dec 31, 2023 |
158.73% |
| Sep 30, 2023 |
43.81% |
| Jun 30, 2023 |
-917.02% |
| Mar 31, 2023 |
-91.29% |
| Dec 31, 2022 |
2,026.41% |
| Sep 30, 2022 |
92.68% |
| Jun 30, 2022 |
-813.00% |
| Mar 31, 2022 |
12.88% |
| Dec 31, 2021 |
110.30% |
| Sep 30, 2021 |
-37.66% |
| Jun 30, 2021 |
-158.07% |
